603040-45-5

Upstream product

• 1779-49-3 Methyltriphenylphosphonium bromide 
• 603040-44-4 [(S)-2-(4-Methoxy-phenyl)-[1,3]dioxolan-4-yl]-acetaldehyde 
• 2186-92-7 p-Anisaldehyde dimethyl acetal 
• 103625-11-2 (2S)-pent-4-ene-1,2-diol 

Downstream Products

• 218898-24-9 (2S)-1,2-di-O-p-methoxybenzylidene-1,2,5-pentanetriol 
• 911237-04-2 (2S)-2-(4-methoxybenzyloxy)-4-pentenol 
• 947619-70-7 (S)-2-(4-methoxybenzyloxy)pent-4-enal 
• 108794-64-5 (S)-methyl 2-hydroxyvalerate 

Relevant academic research and scientific papers

E-Selectin Antagonists Modified By Macrocycle Formation to the Galactose

Provided herein are glycomimetic E-selectin antagonist compounds of formula (I)) and pharmaceutical compositions comprising at least one of the same. The compounds of the present disclosure include trisaccharide domain mimics comprising at least one macro

E-SELECTIN ANTAGONISTS MODIFIED BY MACROCYCLE FORMATION TO THE GALACTOSE

Provided herein are glycomimetic E-selectin antagonist compounds of formula (I)) and pharmaceutical compositions comprising at least one of the same. The compounds of the present disclosure include trisaccharide domain mimics comprising at least one macro

MACROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICALS

The present invention provides compounds having formula (I), and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis, wherein R1 -R11, t, X, Y, Z, and n are as defined herein.